avb-s6-500
Showing 1 - 4 of 4
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial (AVB-S6-500, Paclitaxel, Carboplatin)
Withdrawn
- Epithelial Ovarian Cancer
- +2 more
- AVB-S6-500
- +7 more
- (no location specified)
Sep 23, 2021
Ovarian Cancer Trial in United States (AVB-S6-500, Paclitaxel (Pac), Pegylated liposomal doxorubicin (PLD))
Active, not recruiting
- Ovarian Cancer
- AVB-S6-500
- +3 more
-
Phoenix, Arizona
- +15 more
Feb 16, 2022
Healthy Volunteer Trial in Orlando (AVB-S6-500, Placebo)
Completed
- Healthy Volunteer
- AVB-S6-500
- Placebo
-
Orlando, FloridaOrlando Clinical Research Center
Aug 7, 2018